Telix Pharmaceuticals Crescita futura
Future criteri di controllo 6/6
Telix Pharmaceuticals is forecast to grow earnings and revenue by 38.3% and 21.5% per annum respectively. EPS is expected to grow by 37.9% per annum. Return on equity is forecast to be 26.1% in 3 years.
Informazioni chiave
38.3%
Tasso di crescita degli utili
37.9%
Tasso di crescita dell'EPS
| Biotechs crescita degli utili | 27.1% |
| Tasso di crescita dei ricavi | 21.5% |
| Rendimento futuro del capitale proprio | 26.1% |
| Copertura analitica | Good |
| Ultimo aggiornamento | 04 Nov 2024 |
Aggiornamenti recenti sulla crescita futura
Recent updates
Previsioni di crescita degli utili e dei ricavi
| Data | Ricavi | Guadagni | Flusso di cassa libero | Liquidità dell'operazione | Avg. Numero di analisti |
|---|---|---|---|---|---|
| 12/31/2026 | 1,347 | 180 | 189 | 187 | 9 |
| 12/31/2025 | 1,010 | 82 | 117 | 88 | 9 |
| 12/31/2024 | 770 | 57 | 77 | 71 | 9 |
| 6/30/2024 | 646 | 49 | 25 | 50 | N/A |
| 3/31/2024 | 576 | 32 | 11 | 27 | N/A |
| 12/31/2023 | 503 | 5 | 13 | 24 | N/A |
| 9/30/2023 | 430 | -21 | 7 | 17 | N/A |
| 6/30/2023 | 357 | -48 | 2 | 10 | N/A |
| 3/31/2023 | 249 | -77 | -42 | -31 | N/A |
| 12/31/2022 | 160 | -104 | -78 | -64 | N/A |
| 9/30/2022 | 94 | -111 | -89 | -77 | N/A |
| 6/30/2022 | 29 | -119 | -101 | -91 | N/A |
| 3/31/2022 | 18 | -100 | -81 | -75 | N/A |
| 12/31/2021 | 8 | -81 | -61 | -59 | N/A |
| 9/30/2021 | 7 | -70 | -35 | -34 | N/A |
| 6/30/2021 | 7 | -59 | -9 | -8 | N/A |
| 3/31/2021 | 6 | -52 | -4 | -3 | N/A |
| 12/31/2020 | 5 | -45 | 2 | 2 | N/A |
| 9/30/2020 | 4 | -40 | -13 | -12 | N/A |
| 6/30/2020 | 3 | -36 | -27 | -27 | N/A |
| 3/31/2020 | 3 | -32 | -26 | -25 | N/A |
| 12/31/2019 | 3 | -28 | -24 | -23 | N/A |
| 9/30/2019 | 3 | -23 | -26 | -26 | N/A |
| 6/30/2019 | 2 | -19 | -29 | -29 | N/A |
| 3/31/2019 | 1 | -16 | -25 | -25 | N/A |
| 12/31/2018 | 0 | -14 | -21 | -21 | N/A |
| 9/30/2018 | 0 | -12 | -16 | -16 | N/A |
| 6/30/2018 | N/A | -10 | -11 | -11 | N/A |
| 3/31/2018 | N/A | -8 | N/A | -9 | N/A |
| 12/31/2017 | N/A | -6 | N/A | -6 | N/A |
| 12/31/2016 | N/A | 0 | N/A | N/A | N/A |
Previsioni di crescita futura degli analisti
Guadagni vs tasso di risparmio: TLPP.F's forecast earnings growth (38.3% per year) is above the savings rate (2.5%).
Guadagni vs Mercato: TLPP.F's earnings (38.3% per year) are forecast to grow faster than the US market (15.4% per year).
Guadagni ad alta crescita: TLPP.F's earnings are expected to grow significantly over the next 3 years.
Ricavi vs Mercato: TLPP.F's revenue (21.5% per year) is forecast to grow faster than the US market (8.9% per year).
Ricavi ad alta crescita: TLPP.F's revenue (21.5% per year) is forecast to grow faster than 20% per year.
Previsioni di crescita dell'utile per azione
Rendimento futuro del capitale proprio
ROE futuro: TLPP.F's Return on Equity is forecast to be high in 3 years time (26.1%)